Mostly legal: global conventions on CBD, the harmless cannabis extract

Cannabidiol (CBD) is one of many cannabinoids that can be found in cannabis – the plant from which marijuana, hashish and other drugs are extracted.

While those drugs, and the cannabis plant itself, are illegal in most parts of the world, CBD, which is non-intoxicating, is not.

International regulation takes place under the guidance of the World Health Organization (WHO) and other United Nations agencies.

A WHO committee concluded in 2017 that pure CBD “does not appear to have abuse potential or cause harm”.

Future international attitudes and states’ policies are likely to be strongly influenced by a critical review currently being carried out by a WHO expert committee.

I'm already a subscriber

Pablo Cano Trilla

Head of legal analysis
Pablo runs our regulatory analysis team, leading our international, US and EU coverage in regulatory reports and trackers. Pablo holds an LLM with Distinction from the University of Aberdeen, an LLB in law from the Autonomous University of Madrid and a BA in political science from Pompeu Fabra University. Pablo is a qualified attorney, specialised in international law, EU law & politics, and property law.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization